Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

Also called NCT06325384

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose other
Phase
Not applicable
Enrolled
  • 500 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06325384
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06325384. Randomized; double masking; primary purpose other. Start 2025-02-10 (actual); primary completion 2025-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Acronym
VISION-RWE
Condition
Hypertension
Intervention (Device)
Lifelight
Intervention (Device)
Blood Pressure Cuff
Lead sponsor
Xim Limited (class: industry)
Collaborator
Barts & The London NHS Trust (class: other)
Collaborator
Mind Over Matter Medtech Ltd (class: industry)
Collaborator
Health Innovation Wessex (class: not stated)

Record details

Record id
cardio:ct-nct06325384
Content hash
07ae6b152d37e2ac9cd42525b96fe038c71faaf267b4e0ef3f69f76d23a615a4